Rifabutin: A Possible New Therapeutic Option in Mycobacterium abscessus Infection

摘要

Antibiotic-resistant pathogens are increasingly requiring creativity to achieve successful treatments. One approach is re-examining drugs that are already available for other uses. Mycobacterium abscessus is a rapid-growing nontuberculous mycobacterium that is intrinsically resistant to most drug classes and causes respiratory infections in chronic lung disease patients.